Press releases | Finanzwire

Basculer en Français

10524	Companies
221978	Keywords
151174	Articles
117437	Press releases

Home
Press releases

PRESS RELEASE

published on 09/26/2025 at 08:00, 8 months 10 days ago

Pyrum Innovations AG publishes figures for the first half of 2025
Pyrum Innovations AG publishes figures showing revenue increase and improved EBITDA for the first half of 2025. Earnings forecast maintained for the full year despite lower output expectations

Revenue Increase EBITDA Earnings Forecast Pyrum Innovations AG Output Expectations
PRESS RELEASE

published on 09/26/2025 at 08:00, 8 months 10 days ago

Bitcoin Group SE publishes results for the first half year 2025 – focus on redevelopment of crypto trading platform
Bitcoin Group SE reports 2025 half-year results with focus on redevelopment of crypto trading platform. Decline in revenue due to market volatility. Emphasis on new trading platform development

Revenue Decline Half-year Results Bitcoin Group SE Crypto Trading Platform New Trading Platform
REGULATED PRESS RELEASE

published on 09/26/2025 at 07:30, 8 months 10 days ago

Gimv and EGS Beteiligungen reinforce strategic support for Spineart with CHF 25 million capital increase to accelerate global growth
Spineart secures CHF 25 million investment from Gimv and EGS Beteiligungen to accelerate global expansion in advanced spine surgery solutions

Gimv Investment Spine Surgery EGS Beteiligungen Spineart
PRESS RELEASE

published on 09/26/2025 at 07:30, 8 months 10 days ago

Inside Information / Other news releases
Hoffmann Green Cement announces successful €7.9 million capital increase for commercial and industrial growth. New shares issued at €4.50 unit price. Settlement on September 30, 2025

Capital Increase New Shares Commercial Development Hoffmann Green Cement Industrial Growth
PRESS RELEASE

published on 09/26/2025 at 07:00, 8 months 10 days ago

OSE Immunotherapeutics, Inserm Transfert and Nantes University Announce Strategic Partnership to Accelerate Innovation in Immunotherapy
OSE Immunotherapeutics, Inserm Transfert, and Nantes University form a strategic partnership to advance immunotherapy for oncology, inflammation, and autoimmunity. The collaboration combines academic research and industrial expertise

Innovation Partnership Oncology Collaboration Immunotherapy
PRESS RELEASE

published on 09/26/2025 at 06:30, 8 months 10 days ago

Change in the Chairmanship of the Board of Directors
Change in the Chairmanship of the Board of Directors at Siegfried AG as Dr. Andreas Casutt steps down, proposing Dr. Beat Walti as the new Chairman. Siegfried Holding AG continues its successful growth journey

Board Of Directors Chairmanship Siegfried AG Dr. Andreas Casutt Dr. Beat Walti
PRESS RELEASE

published on 09/26/2025 at 06:12, 8 months 10 days ago

Ad hoc-annoucement pursuant to Art. 53 LR
Adval Tech Management AG releases ad hoc announcement pursuant to Art. 53 LR. For more information, visit www.advaltech.com

Ad Hoc Announcement SIX Swiss Exchange EQS News Adval Tech Management AG Art. 53 LR
PRESS RELEASE

published on 09/26/2025 at 05:15, 8 months 10 days ago

NioCorp Announces Commencement of Proposed Public Offering of Common Shares
NioCorp commences public offering in the United States via Maxim Group LLC for its Elk Creek Project, aiming to raise capital for construction and operations

Elk Creek Project NioCorp Maxim Group LLC Public Offering Capital Raising
PRESS RELEASE

published on 09/26/2025 at 02:01, 8 months 10 days ago

Wellgistics Health Announces Pricing of $5 Million Public Offering
Wellgistics Health, Inc. (NASDAQ: WGRX) announces pricing of public offering of 7,142,862 shares of common stock at $0.70 per share. Gross proceeds expected to be $5 million. Offering by H.C. Wainwright & Co

Public Offering H.C. Wainwright & Co. Pharmaceutical Distribution Wellgistics Health WGRX
PRESS RELEASE

published on 09/25/2025 at 23:30, 8 months 10 days ago

EssilorLuxottica: Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States
EssilorLuxottica's Essilor Stellest lens, the first FDA market authorized spectacle lens in the U.S., clinically proven to slow myopia progression in children, with 71% effectiveness over 2 years

Clinical Data EssilorLuxottica FDA Market Authorization Spectacle Lens Myopia Progression

Accesswire

Published on 06/06/2026 at 04:45, 11 hours 28 minutes ago

Battery X Metals Announces Closing of First Tranche of Private Placement to Advance Corporate Growth
Published on 06/06/2026 at 00:00, 16 hours 13 minutes ago

Onco-Innovations Signs LOI with Nanosoft Polymers to Advance Polymer and Drug Delivery Development for the ONC010 Program
Published on 06/05/2026 at 17:00, 23 hours 13 minutes ago

Silver Spruce Resources Inc. Provides an Update on the Jackie Project Acquisition
Published on 06/05/2026 at 15:00, 1 day 1 hour ago

Norsemont Drills 20 Meters of 1.20 G/T Gold Equivalent at Bottom of Hole
Published on 06/05/2026 at 13:30, 1 day 2 hours ago

CANEX Announces Gold Basin Resources Shareholders Approve Merger Arrangement With CANEX With 75.82% Support

View all ACCESSWIRE

EQS Group

Published on 06/06/2026 at 08:29, 7 hours 44 minutes ago

Starting today, Trade Republic gives European retail investors direct access to IPOs
Published on 06/06/2026 at 00:20, 15 hours 53 minutes ago

Guild Wars 3, Modern Evolution of the MMORPG, Announced at Summer Game Fest for PC and PlayStation 5
Published on 06/05/2026 at 23:05, 17 hours 8 minutes ago

Quantinuum Announces Closing of Upsized Initial Public Offering
Published on 06/05/2026 at 19:06, 21 hours 7 minutes ago

EQS-Adhoc: Brockhaus Technologies AG: The Company's Management Board intends to return approx. €180 million of the proceeds from the sale of the Bikeleasing Group to shareholders
Published on 06/05/2026 at 18:48, 21 hours 25 minutes ago

Digital transformation journey takes centre stage at ANGOTIC 2026

Les Echos

Published on 06/05/2026 at 14:50, 1 day 1 hour ago

Guillemot Corporation | Information regarding the total number of voting rights and shares 31/05/2026
Published on 06/05/2026 at 13:56, 1 day 2 hours ago

Voting rights
Published on 06/04/2026 at 20:00, 1 day 20 hours ago

Schneider Electric announces the reference share price the initial conversion/exchange ratio of its €850 million new bonds convertible into new shares and/or exchangeable for existing shares (OCEANEs) due 2034 and the results of the repurchase of the OC
Published on 06/04/2026 at 18:23, 1 day 21 hours ago

Shareholders’ Meeting and board of directors’ meeting held on June 4, 2026
Published on 06/04/2026 at 18:00, 1 day 22 hours ago

Information concerning the total number of voting rights and shares in the share capital as of May 29, 2026

View all LES ECHOS COMFI WIRE